Opaleye Management Inc.'s Form 4 filing
Protara Therapeutics, Inc. (TARA) · filed Sep 12, 2024
- Accession no.
- 0001493152-24-036106
- Filed
- Sep 12, 2024
- Trade date
- Sep 11-12, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $271.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −31,000 | $1.71F3 | −$53,010 | 2,063,935 | Indirect | |
| Sep 11, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −1,600 | $1.71F3 | −$2,736 | 51,500 | Indirect | |
| Sep 12, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −119,801 | $1.71F4 | −$204,859.71 | 1,944,134 | Indirect | |
| Sep 12, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −6,500 | $1.71F4 | −$11,115 | 45,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70-$1.74 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Referenced by the price of 2 transactions in Table I.
- F4
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70-$1.75 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Referenced by the price of 2 transactions in Table I.